Topical Remetinostat Reduces Disease Burden in Patients With Basal Cell Carcinoma
Remetinostat produced a complete response in 17 of 33 tumors.
All articles by Sucharita Mistry, PhD
Large Study Shows ‘Disappointing’ Treatment Responses in NRG1 Fusion-Driven Lung Cancers
The highest response rate observed with any therapy was 25%.
Frailty Linked to Neurocognitive Decline in Young Adult Survivors of Childhood Cancer
Frail survivors of childhood cancer experienced greater neurocognitive decline.
Medicinal Cannabis Improves Quality of Life for Patients With High-Grade Gliomas
A 1:1 ratio of THC to CBD proved superior to a 4:1 ratio.
No Survival Benefit With Primary Tumor Resection in Stage IV Colorectal Cancer
Phase 3 results refute findings from retrospective studies.
Racial Disparities in Survival Among Triple-Negative Breast Cancer Patients Partially Explained by Treatment Differences
The study showed differences in receipt of chemotherapy and surgery but not radiotherapy.
Bevacizumab Does Not Provide a Survival Benefit in Metastatic Bladder Cancer
There was a significant improvement in progression-free survival with bevacizumab, but it was not considered clinically meaningful.
Nongenetic Risk Factors for Colorectal Cancer May Differ by Disease Onset, Subsite
Some nongenetic risk factors for late-onset colorectal cancer may not be relevant for early-onset disease.
Higher Rates of Breast Tumor Recurrence Following Intraoperative Radiation Therapy
Researchers sought to investigate the long-term outcomes of ELIOT after conserving surgery in early-stage breast cancer compared with whole breast irradiation.
- Loading...
Loading...
Next post in News
Loading... 
Loading...